Creative Diagnostics announces the release of a specialized portfolio of Antibiotic Residue Detection ELISA Kits. NEW YORK, NY, UNITED STATES, January 26, 2026 ...
Avacta Group plc, the developer of Affimer ® biotherapeutics and reagents, is pleased to announce that it will launch an ELISA laboratory test for the SARS-CoV-2 spike protein to support global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results